Yes, yes, malmanu. Your rejoinder is totally appropriate. I guess what I really was saying was that it's great to find someone who agrees with my dream (I admit it's a dream until favourable announcements) that strongly positive CHF interim results will release a tidal wave, a tsunami of instos battling to balance their portfolios to include what could become the greatest blockbuster biotech share of all time ( my 50 years of medical experience backs the latter opinion).
There really are numerous individuals suffocating to death at this moment, and their distressed families, who would pay cash for MPC-150-IM today, almost regardless of price. If the looming interim results confirm earlier extraordinary benefit, the FDA wil be under irresistible pressure to approve the product. I recall another poster, obviously experienced in this area, casting doubt on that scenario of FDA softening their traditional cynicism. I respect that scientific opinion but I much more favour the likelihood of a politically driven response. Good interim CHF results will be bankable to holders.
- Forums
- ASX - By Stock
- MSB
- $5.8 Billion
$5.8 Billion, page-15
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.08 |
Change
0.015(1.42%) |
Mkt cap ! $1.233B |
Open | High | Low | Value | Volume |
$1.08 | $1.10 | $1.06 | $2.231M | 2.069M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 51663 | $1.08 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.08 | 31820 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 59284 | 1.075 |
16 | 53688 | 1.070 |
11 | 68149 | 1.065 |
14 | 98499 | 1.060 |
7 | 100697 | 1.055 |
Price($) | Vol. | No. |
---|---|---|
1.080 | 28935 | 11 |
1.085 | 94948 | 11 |
1.090 | 157343 | 10 |
1.095 | 293075 | 15 |
1.100 | 184330 | 23 |
Last trade - 13.57pm 03/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |